Market Value114,847,122
Total Holdings50
File Date2024-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CLDX / Celldex Therapeutics, Inc.
OLMA / Olema Pharmaceuticals, Inc.
AGIO / Agios Pharmaceuticals, Inc.
KRYS / Krystal Biotech, Inc.
VTYX / Ventyx Biosciences, Inc.
TERN / Terns Pharmaceuticals, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
INSM / Insmed Incorporated
RYTM / Rhythm Pharmaceuticals, Inc.
ESTA / Establishment Labs Holdings Inc.
PEN / Penumbra, Inc.
RDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
TVTX / Travere Therapeutics, Inc.
MASI / Masimo Corporation
ELVN / Enliven Therapeutics, Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
MRNS / Marinus Pharmaceuticals, Inc.
CYTK / Cytokinetics, Incorporated
OCUL / Ocular Therapeutix, Inc.
ITCI / Intra-Cellular Therapies, Inc.
NARI / Inari Medical, Inc.
SWAV / Shockwave Medical, Inc.
AVTE / Aerovate Therapeutics, Inc.
ALPN / Alpine Immune Sciences, Inc.
BIIB / Biogen Inc.
INZY / Inozyme Pharma, Inc.
RNA / Avidity Biosciences, Inc.
EXAS / Exact Sciences Corporation
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
RARE / Ultragenyx Pharmaceutical Inc.
IMAB / I-Mab - Depositary Receipt (Common Stock)
ADAG / Adagene Inc. - Depositary Receipt (Common Stock)
NTRA / Natera, Inc.
APLS / Apellis Pharmaceuticals, Inc.
PROC / Procaps Group S.A.
ABCL / AbCellera Biologics Inc.
MRUS / Merus N.V.
KURA / Kura Oncology, Inc.
SGMT / Sagimet Biosciences Inc.
RZLT / Rezolute, Inc.
AVDL / Avadel Pharmaceuticals plc
GH / Guardant Health, Inc.
ISRG / Intuitive Surgical, Inc.
PMVP / PMV Pharmaceuticals, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
AVRO / AVROBIO, Inc.
VYNE / VYNE Therapeutics Inc.
ALVO / Alvotech
FULC / Fulcrum Therapeutics, Inc.
IRON / Disc Medicine, Inc.
RGLS / Regulus Therapeutics Inc.
AMGN / Amgen Inc.
GOSS / Gossamer Bio, Inc.
MOR / MorphoSys AG - Depositary Receipt (Common Stock)
ARVN / Arvinas, Inc.
SRPT / Sarepta Therapeutics, Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
BBIO / BridgeBio Pharma, Inc.
PACB / Pacific Biosciences of California, Inc.
ATEC / Alphatec Holdings, Inc.
QTTB / Q32 Bio Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
DXCM / DexCom, Inc.
CABA / Cabaletta Bio, Inc.
CRBP / Corbus Pharmaceuticals Holdings, Inc.
ELEV / Elevation Oncology, Inc.
LLY / Eli Lilly and Company
CI / The Cigna Group
QTRX / Quanterix Corporation
TGTX / TG Therapeutics, Inc.
PLRX / Pliant Therapeutics, Inc.
WVE / Wave Life Sciences Ltd.
BHVN / Biohaven Ltd.
GERN / Geron Corporation
RGNX / REGENXBIO Inc.
SYRS / Syros Pharmaceuticals, Inc.
HLVX / HilleVax, Inc.
APRE / Aprea Therapeutics, Inc.